Salute e Benessere

New Data From an Influenza Challenge Study Further Support the Prophylactic…

– INNA-051 increased early expression of multiple antiviral effector genes compared with placebo and shortened viral shedding duration in participants with confirmed influenza infection MELBOURNE, Australia and MILAN, Italy, Sept.11, 2023(GLOBE NEWSWIRE) --ENA Respiratory, a clinical-stage pharmaceutical company, announced positive data from the Phase 2a flu challenge study of INNA-051, a first-in-class, broad-spectrum, innate immunomodulator in development for the prophylaxis of...
Nasdaq GlobeNewswire
11/09/2023

Pharmaceuticals Top Trending Markets - By The Business Research Company

In this thriving pharmaceutical landscape, business intelligence and market insights play a pivotal role in guiding companies towards informed decision-making. Reports from The Business Research Company (TBRC) offer invaluable assistance to businesses within the pharmaceuticals industry. These reports provide comprehensive analyses of market trends, competitive landscapes, and emerging opportunities, allowing pharmaceutical companies to stay ahead of the curve. In this thriving pharmaceutical...
PR Newswire
11/09/2023

Face Mask Market size worth USD 2.7 Billion, Globally, by 2030 at 10.1% CAGR…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=141910 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=141910 Browse in-depth TOCon" Face Mask Market " 202 - Pages 126 – Tables 37 – Figures Global Face Mask Market: Market Drivers, Outlook, and Key Players The global Face Mask Market continues to exhibit remarkable growth, driven by several key factors and dynamic market forces. A comprehensive...
PR Newswire
11/09/2023

Alvotech to Participate in the Morgan Stanley 21st Annual Global Healthcare…

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its participation in the Morgan Stanley 21 stAnnual Global Healthcare Conference in New York on September 11–13, 2023. Ming Li, Chief Strategy Officer, will hold a fireside chat on September 13, 2023 at 12:30 pm EDT. A live audio webcast of the fireside chat will be available and can be accessed either during or after the event in the ...
Nasdaq GlobeNewswire
11/09/2023

MAR Report_VIRBAC SA_4 to 8 September 2023

Statement of transactions in own shares from September 4, 2023 to September 8, 2023BNP PARIBAS EXANE Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of...
Nasdaq GlobeNewswire
11/09/2023

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano…

"I am delighted to welcome Saulo as our new Chief Operating Officer," said Christopher Bath, CEO of Norgine. "Saulo's proven expertise in operational excellence and his dynamic leadership style make him an ideal fit to lead our global operations. We are confident that his strategic insights will further propel Norgine's mission of bringing novel and impactful products to market." "I am delighted to welcome Saulo as our new Chief Operating Officer," said Christopher…
PR Newswire
11/09/2023

Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling…

Regulated Information – Inside Information Waives Key Conditions forUp to €3.5 Million in Atlas FundingReducesCash Covenant and Total Debt for Kreos/PontifaxLoan Leuven, BELGIUM, Boston, MA, US – September 11 , 2023 –Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced today that it has...
Nasdaq GlobeNewswire
11/09/2023

Sharpsmart's Patented Innovation Transforms Sharps Waste Treatment

For decades, fossil fuel-powered high-temperature incineration has been the industry norm for sharps waste – a carbon-intensive process with limited capacity due to ageing infrastructure. For decades, fossil fuel-powered high-temperature incineration has been the industry norm for sharps waste – a carbon-intensive process with limited capacity due to ageing infrastructure. By 2019, the struggling clinical waste incineration infrastructure was making it difficult for healthcare professionals...
PR Newswire
11/09/2023

Crossject announces significant improvement in Gaïa ESG rating

Press Release Crossjectannounces significant improvement in Gaïa ESG ratingScores 73/100, compared with 60 in 2022, with improvements across all themesDemonstrates Crossject's commitment to sustainability and responsible business practices Dijon, France , September 11, 2023 , 7:30 CET– Crossject (ISIN: FR0011716265; Euronext:ALCJ), a specialty pharma company developing needle-free autoinjectors for emergency situations,announces a significant improvement...
Nasdaq GlobeNewswire
11/09/2023

Letter to Shareholders and Corporate Update

Letter to Shareholders and Corporate UpdateLiege, Belgium, 11 September 2023 – 7:30 CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, (the “Company” or “Mithra”), today published a Letter to Shareholders and Corporate Update from Chief Executive Officer, Dr. David Horn Solomon. Dear Fellow Shareholders I have now been CEO of Mithra Pharmaceuticals SA for five months, which makes this a natural point to look back with you at the progress we have...
Nasdaq GlobeNewswire
11/09/2023

Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further…

Agreement with Samsung Bioepis gives Sandoz exclusive commercialization rights to biosimilar SB17 ustekinumab in Europe and North AmericaUstekinumab is a fully human monoclonal antibody to interleukin (IL)-12/23, approved for treatment of plaque psoriasis, psoriatic arthritis, Crohn´s disease and ulcerative colitis Deal further strengthens Sandoz position in immunology and supports further pipeline expansion Basel, September 11, 2023— Sandoz, a global leader in generic and...
Nasdaq GlobeNewswire
11/09/2023

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of…

In the first cohort, administration of 50x106 PMB-CT01 has been extremely well tolerated. Among three treated patients, all three experienced only grade 1 cytokine release syndrome ("CRS") and two had grade 1 immune effector cell-associated neurotoxicity syndrome ("ICANS") with full recovery. The Overall Response Rate is 100% (two Complete Response and one Partial Response) at one-month post treatment. Two patients with mantle cell lymphoma had progressed after conventional…
PR Newswire
11/09/2023

Introducing BIOSTAR® cutting-edge Conventional TBNA (cTBNA) and Endobronchial…

Key features of the BioStar® cTBNA/EBUS-TBNA Needle include: Key features of the BioStar ®cTBNA/EBUS-TBNA Needle include: Precision Engineered Design:The BioStar ® TBNA Needle boasts an advanced, ultra-thin design that ensures minimal tissue disruption, increased accessibility, less puncture force and comfort during sampling. Enhanced Visualization:With its enhanced needle design and clear ultrasound echogenicity the BioStar ®needle provides real-time visualization, enabling...
PR Newswire
08/09/2023

Progress share buy-back program Fagron

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 8 September 2023 – 6PM CET Progress share buy-back program Fagron In the period from 4 September 2023 through 8 September 2023, Fagron purchased 16,146 of its owns shares at an average price of €16.60 per share corresponding to a total amount of €268,005.84. These purchases are part of the share buy-back program of up to 138,372 Fagron shares to fulfill Fagron's obligations under its long term incentive scheme, which...
Nasdaq GlobeNewswire
08/09/2023

Ipsen - Monthly information relative to the total number of voting rights and…

Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1)31 August 202383,814,526Gross total* of...
Nasdaq GlobeNewswire
08/09/2023

Monthly information related to total number of voting rights and shares…

Monthly information related to total number of voting rights and shares composing the share capital _August 31 , 2023 .Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – FranceListing markets:Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com DateTotal of shares composing the share...
Nasdaq GlobeNewswire
08/09/2023

Services Top Trending Markets - By The Business Research Company

In this dynamic landscape, The Business Research Company (TBRC) plays a pivotal role in empowering businesses within the services industry. TBRC's comprehensive reports provide valuable insights, market intelligence, and trend analyses that enable businesses to make informed decisions, stay competitive, and seize emerging opportunities. In this dynamic landscape, The Business Research Company (TBRC) plays a pivotal role in empowering businesses within the services industry. TBRC's…
PR Newswire
08/09/2023

Healthcare Finance Solutions Market to Reach $276.04 billion, Globally, by 2032…

Request PDF Sample: https://www.alliedmarketresearch.com/request-sample/186067 Request PDF Sample: https://www.alliedmarketresearch.com/request-sample/186067 Healthcare finance solutions has been harnessed for world-building and level design. Game developers can now use procedural generation techniques, often powered by GANs or other generative models, to create vast and dynamic game environments without the need for manual design of every element. This significantly speeds up the...
PR Newswire
08/09/2023

Clinical Trials Market worth $73.2 billion | MarketsandMarkets

The global clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The global clinical trials market is growing owing to factors such as increased R&D spending, increasing outsourcing of R&D operations, and an increase in clinical trials conducted globally. In addition to this, the growing biosimilars and biologics development and launches, increasing demand for specialized testing…
PR Newswire
08/09/2023

Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept®…

Under the terms of the agreement, Sirtex will exclusively distribute Magle Group's chemoembolization product, EmboCept® S DSM 50 μm, in the existing and new geographic areas to support expanded patient access to the product. Together, Sirtex and Magle also intend to establish a joint development plan to increase product range in the field of embolization by utilizing Magle Group's DSM platform. Under the terms of the agreement, Sirtex will exclusively distribute Magle Group's…
PR Newswire
08/09/2023

Pharmaceuticals Top Trending Markets - By The Business Research Company

In this thriving pharmaceutical landscape, business intelligence and market insights play a pivotal role in guiding companies towards informed decision-making. Reports from The Business Research Company (TBRC) offer invaluable assistance to businesses within the pharmaceuticals industry. These reports provide comprehensive analyses of market trends, competitive landscapes, and emerging opportunities, allowing pharmaceutical companies to stay ahead of the curve. In this thriving pharmaceutical...
PR Newswire
08/09/2023

BIZCLIK MEDIA LAUNCHES SEPTEMBER EDITION OF HEALTHCARE DIGITAL

The digital edition of Healthcare Digital, is a trusted industry source for in-depth reports and interviews with the leading minds in the manufacturing sector. The digital edition ofHealthcare Digital,is a trusted industry source for in-depth reports and interviews with the leading minds in the manufacturing sector. Healthcare Digital This month's edition features an extensive lead interview with,Penny Pinnock, Business Development Manager at Siemens Financial Services about...
PR Newswire
08/09/2023

Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By…

The Fortune Business Insights report said: "After the outbreak of COVID-19, several medical associations reported a spike in cases of dry eye due to continuous use of face masks among people. Also, as the incidence of other infectious diseases, especially air borne diseases grows, the adoption of masks is expected to continue in the forecast period. This prevailing trend will drive the adoption rate of these products leading to market growth during the forecast period (2030). One of the…
PR Newswire
08/09/2023

Sobi KOL investor event: Advancing the standard of care in haemophilia

The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com prior to the conference call. The presentation can be followed livehereor afterwards onsobi.com. The slides will be made available onsobi.com prior to the conference call. To participate in the conference call, please use the following dial-in details: Sweden : +46 (0)8 5051 0031 United Kingdom : +44 (0) 207 107 06 13 For other countries, please get details...
PR Newswire
08/09/2023
Altri  Comunicati